The FDA is slated to make a decision on whether to approve Pfizer’s shot in August before respiratory syncytial virus season in the fall.
You are here: Home / FDA advisors recommend Pfizer’s RSV vaccine for infants but raise safety concerns
Market News and Views
The FDA is slated to make a decision on whether to approve Pfizer’s shot in August before respiratory syncytial virus season in the fall.